Clearview Wealth Advisors’s BioNTech BNTX Stock Holding History

Clearview Wealth Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20	Closed	-$2.16K	–	173
2023 Q2	$2.16K	Hold	20	–	–	﹤0.01%	523
2023 Q1	$2.49K	Hold	20	–	–	﹤0.01%	495
2022 Q4	$3K	Hold	20	–	–	﹤0.01%	448
2022 Q3	$3K	Hold	20	–	–	﹤0.01%	447
2022 Q2	$3K	Hold	20	–	–	﹤0.01%	467
2022 Q1	$3K	Hold	20	–	–	﹤0.01%	483
2021 Q4	$5K	Hold	20	–	–	﹤0.01%	482
2021 Q3	$5K	Hold	20	–	–	﹤0.01%	492
2021 Q2	$4K	Hold	20	–	–	﹤0.01%	520
2021 Q1	$2K	Hold	20	–	–	﹤0.01%	541
2020 Q4	$2K	Buy	+20	New	+$1.96K	﹤0.01%	503

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Clearview Wealth Advisors's BNTX Position: Q3 2023 in Review

Clearview Wealth Advisors sold out of BioNTech (BNTX) in Q3 2023, closing a stake of 20 shares — an estimated $2.16K sold.

Clearview Wealth Advisors first reported a position in BNTX in Q4 2020 and held it in 11 quarters. The position peaked at $5K in Q4 2021. 252 funds tracked by Wall St. Rank hold BNTX as of Q3 2023.

Clearview Wealth Advisors reported no remaining BioNTech position as of Q3 2023 after selling out during the quarter.
Clearview Wealth Advisors sold 20 BioNTech shares in Q3 2023, an estimated $2.16K.
Clearview Wealth Advisors first reported a position in BioNTech in Q4 2020 and held it in 11 quarters.
Clearview Wealth Advisors's BioNTech position peaked at $5K in Q4 2021.
252 funds tracked by Wall St. Rank held BioNTech as of Q3 2023.

Based on Clearview Wealth Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.